
Journal of Organic Chemistry p. 8006 - 8018 (2019)
Update date:2022-07-30
Topics:
Molinaro, Carmela
Phillips, Eric M.
Xiang, Bangping
Milczek, Erika
Shevlin, Michael
Balsells, Jaume
Ceglia, Scott
Chen, Jiahui
Chen, Lu
Chen, Qinghao
Fei, Zhongbo
Hoerrner, Scott
Qi, Ji
De Lera Ruiz, Manuel
Tan, Lushi
Wan, Baoqiang
Yin, Jingjun
A practical and efficient enantioselective synthesis of the calcitonin gene-related peptide receptor antagonist 1 has been developed. The key structural component of the active pharmaceutical ingredient is a syn-1,2-amino-fluoropiperidine 4. Two approaches were developed to synthesize this important pharmacophore. Initially, Ru-catalyzed asymmetric hydrogenation of fluoride-substituted enamide 8 enabled the synthesis of sufficient quantities of compound 1 to support early preclinical studies. Subsequently, a novel, cost-effective route to this intermediate was developed utilizing a dynamic kinetic asymmetric transamination of ketone 9. This synthesis also features a robust Ullmann coupling to install a bis-aryl ether using a soluble Cu(I) catalyst. Finally, an enzymatic desymmetrization of meso-diester 7 was exploited for the construction of the γ-lactam moiety in 1.
View MoreLiaoning Yufeng Chemical Co.,Ltd.
Contact:86-0419-3418888
Address:The metallurgical industrial zone,shoushan town, Liaoyang, Liaoning, China
Tianjin Emulsion Science&Technology Development Co.,Ltd
Contact:13901380442
Address:Vake Garden New Town New Yi Bai Road Beichen District Tianjin,China
Shandong Jiulong Hisince Pharmaceutical Co.,Ltd.
Contact:+86-15853188990
Address:Huadian Pioneer Park, Huadian Township, Qihe County, Dezhou City, Shandong, P.R.China
Contact:+86-18653358619
Address:zibo
Contact:+86-18653358619
Address:zibo
Doi:10.1016/S0040-4039(03)00614-2
(2003)Doi:10.1002/anie.201301591
(2013)Doi:10.1023/A:1012380212140
(2001)Doi:10.1039/jr9480002138
(1948)Doi:10.1002/cssc.201900928
(2019)Doi:10.1016/S0040-4039(00)78844-7
(1980)